+1.49%
Today
Loading 1D prices…
Company profile
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
San Jose, CA, United States
Employees
888
Fiscal year end
1231
CIK
1588978
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| TNDMTandem Diabetes Care Inc. Common Stock | $1.2B | $1B | -20.17% | -$3.04 | -6.66% | Buy |
| IARTIntegra LifeSciences Holdings Corporation Common Stock | $1.2B | $1.6B | -31.60% | -$6.74 | -0.26% | Hold |
| AORTArtivion Inc. Common Stock | $1.2B | $441.3M | +2.21% | $0.21 | +1.70% | Buy |
| IRMDiRadimed Corporation Common Stock | $1.1B | $83.8M | +26.82% | $1.75 | +0.43% | Buy |
| DRTSAlpha Tau Medical Ltd. Ordinary Shares | $1.3B | $0.00 | — | -$0.53 | -0.10% | Hold |